Angion Biomedica Company

Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Technology: Data-driven Technologies
Industry: Biopharma, Biotechnology, Medical
Headquarters: Uniondale, New York, United States
Founded Date: 1998
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: 44356452
Estimated Revenue: $10M to $50M
Last Funding Date: 2021
Last Funding Type: Post-IPO Equity

Visit Website
mail@angion.com
Register and Claim Ownership